Yuping Du
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
- RNA Research and Splicing
Papers in
-
- Circular RNAs in diseases 7
- PI3K/AKT/mTOR signaling in cancer 7
- RNA modifications and cancer 6
- RNA Research and Splicing 4
-
- MicroRNA in disease regulation 6
- Cancer-related molecular mechanisms research 6
- Co-authors
- Yang Zhao (9 shared papers)Shuo Chen (6 shared papers)Zhi‐Hong Zong (3 shared papers)Zhenghao Huang (2 shared papers)Xue Guan (4 shared papers)Jinbo Yang (10 shared papers)Xing Chen (5 shared papers)Nan Jing (7 shared papers)
- Journals
- PLoS ONE (3 papers)Cell Death Discovery (2 papers)Proceedings of the National Academy of Sciences (2 papers)Molecular Pharmacology (1 paper)Foods (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Yuping Du
35 papers receiving 1.2k citations
Yuping Du's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 443
- Molecular Biology 843
- Oncology 261
- Immunology 160
- Pharmacology 55
Countries citing papers authored by Yuping Du
This map shows the geographic impact of Yuping Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuping Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuping Du more than expected).
Fields of papers citing papers by Yuping Du
This network shows the impact of papers produced by Yuping Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuping Du. The network helps show where Yuping Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Yuping Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 259 | |
| 2 | 2022 | 117 | |
| 3 | 2019 | 111 | |
| 4 | 2014 | 78 | |
| 5 | 2019 | 60 | |
| 6 | 2013 | 59 | |
| 7 | 2024 | 45 | |
| 8 | 2017 | 41 | |
| 9 | 2021 | 40 | |
| 10 | 2010 | 38 | |
| 11 | 2021 | 36 | |
| 12 | 2017 | 36 | |
| 13 | 2018 | 31 | |
| 14 | 2018 | 27 | |
| 15 | 2012 | 25 | |
| 16 | 2021 | 24 | |
| 17 | 2020 | 21 | |
| 18 | 2011 | 20 | |
| 19 | Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancer Hit paper breakdown → | 2025 | 18 |
| 20 | 2014 | 15 |
About Yuping Du
Yuping Du is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Organic Chemistry, having authored 36 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cytokine Signaling Pathways and Interactions (9 papers), Circular RNAs in diseases (7 papers), PI3K/AKT/mTOR signaling in cancer (7 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers), Cancer Mechanisms and Therapy (5 papers) and RNA Research and Splicing (4 papers). The work is most often cited by research in Cancer Research (443 citations), Molecular Biology (843 citations), Oncology (261 citations), Immunology (160 citations) and Pharmacology (55 citations). Yuping Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yang Zhao, Shuo Chen, Zhi‐Hong Zong, Zhenghao Huang, Xue Guan, Jinbo Yang, Xing Chen, Nan Jing, George R. Stark and Tao Lu. Their work appears in journals such as PLoS ONE, Cell Death Discovery, Proceedings of the National Academy of Sciences, Molecular Pharmacology and Foods.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.